A total of 1 million stem celltransplants have been performed worldwide. Today, more than 70 cancerand non-Cancerous diseases are typically treated with a stem celltransplant. Survival rates have increased significantly among patients whoreceived blood stem celltransplants from both related and unrelated donors. Recent research done on38,000 patients who are affected with serious blood cancerand diseases over a 12-year period shows the significant improvement in theirsurvival rates from 48- 63 percent. For a long time, stem celltransplant activity was limited to patients with coordinated familycontributors (range of 30% of the patients), random donor registries will bevery less (i.e.) 1 out 500.000. At present, cordblood has been utilized as an alternate of donor and achieved more than2000 Cordblood Haematopoietic Stem CellTransplants yearly.
Related: Stemcells Meetings | Stemcell Summit | Regenerativemedicine Workshops | TissueEngineering Congress | TissueScience Symposium | CancerConference | CellsScience Conferences | BiomarkersEvents
Related Conference:
International Conferenceon Tissue science and Regenerativemedicine, Nov 19- 20, Paris, France; Translationalof stem cells to the clinic: Challenges and Opportunities,Dec 2- 4, 2018, Los angles, USA; Stemcells & Organoidsin Development & Disease,Feb 20- 22, 2019, Amsterdam, Netherlands; 2nd International Conferenceon Wound Care, TissueRepair and RegenerativeMedicine, February 21-22, 2019, Paris, France; International Conferenceon Biomarkers, March 11- 12, 2019, London, UK; 2nd International Conferenceon Stem cells and Regenerativemedicine, March 14- 15, 2019, London, UK; International Conferenceon Tissue engineering and Regenerative medicine,March 14-15, London, UK
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
